Advertisement

Index by author

August 01, 1983; Volume 226,Issue 2

A

  1. Aass, H

    1. Demonstration of an alpha adrenoceptor-mediated inotropic effect of norepinephrine in rabbit papillary muscle.
      H Aass, T Skomedal and J B Osnes
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 572-578;

  2. Abiko, Y

    1. Effects of 1-(4-nitrophenyl)-2-isopropylaminoethanol (INPEA) and propranolol and their dextro-isomers on hemodynamic and metabolic responses to isoproterenol in dogs.
      T Nishimura, S Kita and Y Abiko
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 595-602;

  3. Akera, T

    1. Ischemia-induced enhancement of digitalis sensitivity in isolated guinea-pig heart.
      D H Kim, T Akera and R H Kennedy
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 335-342;

  4. Ali, B

    1. Mammalian tissue acetylsalicylic acid esterase(s): identification, distribution and discrimination from other esterases.
      B Ali and S Kaur
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 589-594;

  5. Ali, F M

    1. Similarity between tyramine-induced neurotoxicity and the coma of Reye's syndrome.
      B A Faraj, D B Caplan, E J Malveaux, V M Camp and F M Ali
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 608-615;

  6. Allen, T M

    1. Effect of liposome size and drug release properties on pharmacokinetics of encapsulated drug in rats.
      T M Allen and J M Everest
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 539-544;

  7. Arbilla, S

    1. Changes in sensitivity of release modulating dopamine autoreceptors after chronic treatment with haloperidol.
      J Z Nowak, S Arbilla, A M Galzin and S Z Langer
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 558-564;

  8. Armbrecht, H J

    1. Ethanol-induced disordering of membranes from different age groups of C57BL/6NNIA mice.
      H J Armbrecht, W G Wood, R W Wise, J B Walsh, B N Thomas and R Strong
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 387-391;

B

  1. Banning, J W

    1. Evaluation of the adrenergic effects of a novel optically active catecholamidine in vitro and in vivo: differential application of the Easson-Stedman hypothesis to alpha and beta adrenoceptors.
      R R Ruffolo, J W Banning, P N Patil, A Hamada and D D Miller
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 469-476;

  2. Barnett, A

    1. SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems.
      L C Iorio, A Barnett, F H Leitz, V P Houser and C A Korduba
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 462-468;

  3. Bianchi, B R

    1. Differential sensitivity of hypothalamic norepinephrine and striatal dopamine to catecholamine-depleting agents.
      G S Takimoto, J D Stittsworth, B R Bianchi and J K Stephens
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 432-439;

  4. Blas, C

    1. Chlordiazepoxide reduces in vivo serotonin release in the basal ganglia of encéphale isolé but not anesthetized cats: evidence for a dorsal raphe site of action.
      P Soubrie, C Blas, A Ferron and J Glowinski
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 526-532;

  5. Branch, R A

    1. Prostaglandin biosynthesis does not participate in hypercapnia-induced cerebral vasodilatation in the dog.
      E K Jackson, J F Gerkens, J B Zimmerman, H D Uderman, J A Oates, R J Workman and R A Branch
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 486-492;

  6. Breese, G R

    1. Pharmacokinetics of methylphenidate in man, rat and monkey.
      W Wargin, K Patrick, C Kilts, C T Gualtieri, K Ellington, R A Mueller, G Kraemer and G R Breese
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 382-386;

  7. Brocco, M J

    1. Effects of chronic phencyclidine administration on the schedule-controlled behavior of rats.
      M J Brocco, S K Rastogi and D E McMillan
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 449-454;

  8. Brookins, J

    1. Erythropoietic effects of prostacyclin (PGI2) and its metabolite 6-keto-prostaglandin (PG)E1.
      P K Nelson, J Brookins and J W Fisher
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 493-499;

  9. Brown, J H

    1. Relationships between choline uptake, acetylcholine synthesis and acetylcholine release in isolated rat atria.
      G T Wetzel and J H Brown
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 343-348;

  10. Brown, N L

    1. Pre- and postjunctional actions of hydralazine in vascular and nonvascular smooth muscle in vitro.
      N L Brown, C Chevillard and M Worcel
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 512-518;

  11. Buckalew, V M

    1. Synergistic effect of modest volume expansion on the diuretic and natriuretic action of guanabenz.
      J W Strandhoy, M Morris, B D Steg and V M Buckalew
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 419-424;

  12. Burks, T F

    1. Centrally mediated inhibition of small intestinal transit and motility by morphine in the rat.
      J J Galligan and T F Burks
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 356-361;

C

  1. Camp, V M

    1. Similarity between tyramine-induced neurotoxicity and the coma of Reye's syndrome.
      B A Faraj, D B Caplan, E J Malveaux, V M Camp and F M Ali
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 608-615;

  2. Caplan, D B

    1. Similarity between tyramine-induced neurotoxicity and the coma of Reye's syndrome.
      B A Faraj, D B Caplan, E J Malveaux, V M Camp and F M Ali
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 608-615;

  3. Chee, O

    1. Naltrexone effects on plasma vasopressin concentration elevated and lowered by various stimuli.
      L M Rosella-Dampman, L C Keil, O Chee and J Y Summy-Long
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 373-381;

  4. Chevillard, C

    1. Pre- and postjunctional actions of hydralazine in vascular and nonvascular smooth muscle in vitro.
      N L Brown, C Chevillard and M Worcel
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 512-518;

  5. Costa, L G

    1. [3H]Nicotine binding in rat brain: alteration after chronic acetylcholinesterase inhibition.
      L G Costa and S D Murphy
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 392-397;

  6. Cragoe, E

    1. Inhibition of Na+ influx and DNA synthesis in human fibroblasts and neuroblastoma-glioma hybrid cells by amiloride analogs.
      M E O'Donnell, E Cragoe and M L Villereal
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 368-372;

D

  1. Daniell, H B

    1. Adrenergic nerve stimulation-induced release of propranolol from the perfused hindlimb and spleen of the dog and associated changes in postjunctional response.
      M P Russell, J G Webb, T Walle, H B Daniell, P J Privitera and T E Gaffney
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 324-329;

  2. de Jonge, A

    1. Quantitative aspects of alpha adrenergic effects induced by clonidine-like imidazolidines. III. Comparison of central and peripheral alpha-1 and alpha-2 adrenoceptors.
      A de Jonge, P B Timmermans and P A van Zwieten
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 565-571;

  3. Dietz, T H

    1. Production of prostaglandins E2 and F2 alpha in the freshwater mussel Ligumia subrostrata: relation to sodium transport.
      D G Saintsing, D H Hwang and T H Dietz
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 455-461;

  4. Dykstra, L A

    1. Behavioral effects of buprenorphine and diprenorphine under a multiple schedule of food presentation in squirrel monkeys.
      L A Dykstra
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 317-323;

E

  1. Ellington, K

    1. Pharmacokinetics of methylphenidate in man, rat and monkey.
      W Wargin, K Patrick, C Kilts, C T Gualtieri, K Ellington, R A Mueller, G Kraemer and G R Breese
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 382-386;

  2. Everest, J M

    1. Effect of liposome size and drug release properties on pharmacokinetics of encapsulated drug in rats.
      T M Allen and J M Everest
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 539-544;

F

  1. Faraj, B A

    1. Similarity between tyramine-induced neurotoxicity and the coma of Reye's syndrome.
      B A Faraj, D B Caplan, E J Malveaux, V M Camp and F M Ali
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 608-615;

  2. Ferron, A

    1. Chlordiazepoxide reduces in vivo serotonin release in the basal ganglia of encéphale isolé but not anesthetized cats: evidence for a dorsal raphe site of action.
      P Soubrie, C Blas, A Ferron and J Glowinski
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 526-532;

  3. Feuer, C

    1. Suppression of lymphatic vessel contractility with inhibitors of arachidonic acid metabolism.
      M G Johnston and C Feuer
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 603-607;

  4. Fisher, J W

    1. Erythropoietic effects of prostacyclin (PGI2) and its metabolite 6-keto-prostaglandin (PG)E1.
      P K Nelson, J Brookins and J W Fisher
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 493-499;

  5. Foltin, R W

    1. Interaction between the effects of intragastric meals and drugs on feeding in rhesus monkeys.
      R W Foltin and C R Schuster
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 405-410;
    2. Effects of psychomotor stimulants, alone and in pairs, on milk drinking in the rat after intraperitoneal and intragastric administration.
      R W Foltin, W L Woolverton and C R Schuster
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 411-418;

  6. Fregly, M J

    1. Effects of chronic administration of mestranol on alpha and beta adrenergic responsiveness in female rats.
      K T Shiverick, K Hutchins, D C Kikta, N Squires and M J Fregly
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 362-367;

  7. Fugman, D A

    1. Calcium and calmodulin antagonists binding to calmodulin and relaxation of coronary segments.
      J D Johnson and D A Fugman
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 330-334;

  8. Fujiwara, M

    1. Effects of Met-enkephalin on the substance P-ergic and cholinergic responses in the rabbit iris sphincter muscle.
      N Ueda, I Muramatsu, H Hayashi and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 507-511;

G

  1. Gaffney, T E

    1. Adrenergic nerve stimulation-induced release of propranolol from the perfused hindlimb and spleen of the dog and associated changes in postjunctional response.
      M P Russell, J G Webb, T Walle, H B Daniell, P J Privitera and T E Gaffney
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 324-329;

  2. Gale, K

    1. Effect of dopamine agonists on gamma-aminobutyric acid (GABA) turnover in the superior colliculus: evidence that nigrotectal GABA projections are under the influence of dopaminergic transmission.
      M R Melis and K Gale
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 425-431;

  3. Galligan, J J

    1. Centrally mediated inhibition of small intestinal transit and motility by morphine in the rat.
      J J Galligan and T F Burks
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 356-361;

  4. Galzin, A M

    1. Changes in sensitivity of release modulating dopamine autoreceptors after chronic treatment with haloperidol.
      J Z Nowak, S Arbilla, A M Galzin and S Z Langer
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 558-564;

  5. Gardocki, J F

    1. Anti-inflammatory and antiarthritic evaluation of acetaminophen and its potentiation of tolmetin.
      S Wong and J F Gardocki
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 625-632;

  6. Gerkens, J F

    1. Prostaglandin biosynthesis does not participate in hypercapnia-induced cerebral vasodilatation in the dog.
      E K Jackson, J F Gerkens, J B Zimmerman, H D Uderman, J A Oates, R J Workman and R A Branch
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 486-492;

  7. Gillis, R A

    1. Pentobarbital causes cardiorespiratory depression by interacting with a GABAergic system at the ventral surface of the medulla.
      K A Yamada, J M Moerschbaecher, P Hamosh and R A Gillis
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 349-355;

  8. Glowinski, J

    1. Chlordiazepoxide reduces in vivo serotonin release in the basal ganglia of encéphale isolé but not anesthetized cats: evidence for a dorsal raphe site of action.
      P Soubrie, C Blas, A Ferron and J Glowinski
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 526-532;

  9. Gualtieri, C T

    1. Pharmacokinetics of methylphenidate in man, rat and monkey.
      W Wargin, K Patrick, C Kilts, C T Gualtieri, K Ellington, R A Mueller, G Kraemer and G R Breese
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 382-386;

H

  1. Hamada, A

    1. Evaluation of the adrenergic effects of a novel optically active catecholamidine in vitro and in vivo: differential application of the Easson-Stedman hypothesis to alpha and beta adrenoceptors.
      R R Ruffolo, J W Banning, P N Patil, A Hamada and D D Miller
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 469-476;

  2. Hamosh, P

    1. Pentobarbital causes cardiorespiratory depression by interacting with a GABAergic system at the ventral surface of the medulla.
      K A Yamada, J M Moerschbaecher, P Hamosh and R A Gillis
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 349-355;

  3. Hayashi, E

    1. Correlation between cholinesterase inhibition and reduction in muscarinic receptors and choline uptake by repeated diisopropylfluorophosphate administration: antagonism by physostigmine and atropine.
      S Yamada, M Isogai, H Okudaira and E Hayashi
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 519-525;

  4. Hayashi, H

    1. Effects of Met-enkephalin on the substance P-ergic and cholinergic responses in the rabbit iris sphincter muscle.
      N Ueda, I Muramatsu, H Hayashi and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 507-511;

  5. Herman, A G

    1. Accumulation and release of [3H]-5-hydroxytryptamine in saphenous veins and cerebral arteries of the dog.
      T J Verbeuren, F H Jordaens and A G Herman
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 579-588;

  6. Houser, V P

    1. SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems.
      L C Iorio, A Barnett, F H Leitz, V P Houser and C A Korduba
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 462-468;

  7. Hutchins, K

    1. Effects of chronic administration of mestranol on alpha and beta adrenergic responsiveness in female rats.
      K T Shiverick, K Hutchins, D C Kikta, N Squires and M J Fregly
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 362-367;

  8. Hwang, D H

    1. Production of prostaglandins E2 and F2 alpha in the freshwater mussel Ligumia subrostrata: relation to sodium transport.
      D G Saintsing, D H Hwang and T H Dietz
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 455-461;

  9. Hylden, J L

    1. Pharmacological characterization of substance P-induced nociception in mice: modulation by opioid and noradrenergic agonists at the spinal level.
      J L Hylden and G L Wilcox
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 398-404;

I

  1. Iorio, L C

    1. SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems.
      L C Iorio, A Barnett, F H Leitz, V P Houser and C A Korduba
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 462-468;

  2. Isogai, M

    1. Correlation between cholinesterase inhibition and reduction in muscarinic receptors and choline uptake by repeated diisopropylfluorophosphate administration: antagonism by physostigmine and atropine.
      S Yamada, M Isogai, H Okudaira and E Hayashi
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 519-525;

J

  1. Jackson, E K

    1. Prostaglandin biosynthesis does not participate in hypercapnia-induced cerebral vasodilatation in the dog.
      E K Jackson, J F Gerkens, J B Zimmerman, H D Uderman, J A Oates, R J Workman and R A Branch
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 486-492;

  2. Johnson, J D

    1. Calcium and calmodulin antagonists binding to calmodulin and relaxation of coronary segments.
      J D Johnson and D A Fugman
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 330-334;

  3. Johnston, M G

    1. Suppression of lymphatic vessel contractility with inhibitors of arachidonic acid metabolism.
      M G Johnston and C Feuer
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 603-607;

  4. Jordaens, F H

    1. Accumulation and release of [3H]-5-hydroxytryptamine in saphenous veins and cerebral arteries of the dog.
      T J Verbeuren, F H Jordaens and A G Herman
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 579-588;

K

  1. Kaur, S

    1. Mammalian tissue acetylsalicylic acid esterase(s): identification, distribution and discrimination from other esterases.
      B Ali and S Kaur
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 589-594;

  2. Keil, L C

    1. Naltrexone effects on plasma vasopressin concentration elevated and lowered by various stimuli.
      L M Rosella-Dampman, L C Keil, O Chee and J Y Summy-Long
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 373-381;

  3. Kennedy, R H

    1. Ischemia-induced enhancement of digitalis sensitivity in isolated guinea-pig heart.
      D H Kim, T Akera and R H Kennedy
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 335-342;

  4. Kharasch, E D

    1. Inhibitory effects of anthracenedione antineoplastic agents on hepatic and cardiac lipid peroxidation.
      E D Kharasch and R F Novak
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 500-506;

  5. Kikta, D C

    1. Effects of chronic administration of mestranol on alpha and beta adrenergic responsiveness in female rats.
      K T Shiverick, K Hutchins, D C Kikta, N Squires and M J Fregly
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 362-367;

  6. Kilts, C

    1. Pharmacokinetics of methylphenidate in man, rat and monkey.
      W Wargin, K Patrick, C Kilts, C T Gualtieri, K Ellington, R A Mueller, G Kraemer and G R Breese
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 382-386;

  7. Kim, D H

    1. Ischemia-induced enhancement of digitalis sensitivity in isolated guinea-pig heart.
      D H Kim, T Akera and R H Kennedy
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 335-342;

  8. Kita, S

    1. Effects of 1-(4-nitrophenyl)-2-isopropylaminoethanol (INPEA) and propranolol and their dextro-isomers on hemodynamic and metabolic responses to isoproterenol in dogs.
      T Nishimura, S Kita and Y Abiko
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 595-602;

  9. Korduba, C A

    1. SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems.
      L C Iorio, A Barnett, F H Leitz, V P Houser and C A Korduba
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 462-468;

  10. Koster, A S

    1. Glucuronidation in isolated perfused rat intestinal segments after mucosal and serosal administration of 1-naphthol.
      A S Koster and J Noordhoek
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 533-538;

  11. Kow, L M

    1. Spinal serotonin (5-HT) receptor subtypes and nociception.
      F P Zemlan, L M Kow and D W Pfaff
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 477-485;

  12. Kraemer, G

    1. Pharmacokinetics of methylphenidate in man, rat and monkey.
      W Wargin, K Patrick, C Kilts, C T Gualtieri, K Ellington, R A Mueller, G Kraemer and G R Breese
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 382-386;

L

  1. Lalley, P M

    1. Biphasic effects of baclofen on phrenic motoneurons: possible involvement of two types of gamma-aminobutyric acid (GABA) receptors.
      P M Lalley
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 616-624;

  2. Langer, S Z

    1. Changes in sensitivity of release modulating dopamine autoreceptors after chronic treatment with haloperidol.
      J Z Nowak, S Arbilla, A M Galzin and S Z Langer
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 558-564;

  3. Leitz, F H

    1. SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems.
      L C Iorio, A Barnett, F H Leitz, V P Houser and C A Korduba
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 462-468;

M

  1. Malveaux, E J

    1. Similarity between tyramine-induced neurotoxicity and the coma of Reye's syndrome.
      B A Faraj, D B Caplan, E J Malveaux, V M Camp and F M Ali
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 608-615;

  2. McMillan, D E

    1. Behavioral effects of the optical isomers of methadone in the rat during acute and chronic administration.
      L A Raitano and D E McMillan
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 440-448;
    2. Effects of chronic phencyclidine administration on the schedule-controlled behavior of rats.
      M J Brocco, S K Rastogi and D E McMillan
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 449-454;

  3. Melis, M R

    1. Effect of dopamine agonists on gamma-aminobutyric acid (GABA) turnover in the superior colliculus: evidence that nigrotectal GABA projections are under the influence of dopaminergic transmission.
      M R Melis and K Gale
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 425-431;

  4. Miller, D D

    1. Evaluation of the adrenergic effects of a novel optically active catecholamidine in vitro and in vivo: differential application of the Easson-Stedman hypothesis to alpha and beta adrenoceptors.
      R R Ruffolo, J W Banning, P N Patil, A Hamada and D D Miller
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 469-476;

  5. Moerschbaecher, J M

    1. Pentobarbital causes cardiorespiratory depression by interacting with a GABAergic system at the ventral surface of the medulla.
      K A Yamada, J M Moerschbaecher, P Hamosh and R A Gillis
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 349-355;

  6. Morris, M

    1. Synergistic effect of modest volume expansion on the diuretic and natriuretic action of guanabenz.
      J W Strandhoy, M Morris, B D Steg and V M Buckalew
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 419-424;

  7. Mueller, R A

    1. Pharmacokinetics of methylphenidate in man, rat and monkey.
      W Wargin, K Patrick, C Kilts, C T Gualtieri, K Ellington, R A Mueller, G Kraemer and G R Breese
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 382-386;

  8. Muramatsu, I

    1. Effects of Met-enkephalin on the substance P-ergic and cholinergic responses in the rabbit iris sphincter muscle.
      N Ueda, I Muramatsu, H Hayashi and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 507-511;

  9. Murphy, S D

    1. [3H]Nicotine binding in rat brain: alteration after chronic acetylcholinesterase inhibition.
      L G Costa and S D Murphy
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 392-397;

N

  1. Nelson, P K

    1. Erythropoietic effects of prostacyclin (PGI2) and its metabolite 6-keto-prostaglandin (PG)E1.
      P K Nelson, J Brookins and J W Fisher
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 493-499;

  2. Nishimura, T

    1. Effects of 1-(4-nitrophenyl)-2-isopropylaminoethanol (INPEA) and propranolol and their dextro-isomers on hemodynamic and metabolic responses to isoproterenol in dogs.
      T Nishimura, S Kita and Y Abiko
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 595-602;

  3. Noordhoek, J

    1. Glucuronidation in isolated perfused rat intestinal segments after mucosal and serosal administration of 1-naphthol.
      A S Koster and J Noordhoek
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 533-538;

  4. Novak, R F

    1. Inhibitory effects of anthracenedione antineoplastic agents on hepatic and cardiac lipid peroxidation.
      E D Kharasch and R F Novak
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 500-506;

  5. Nowak, J Z

    1. Changes in sensitivity of release modulating dopamine autoreceptors after chronic treatment with haloperidol.
      J Z Nowak, S Arbilla, A M Galzin and S Z Langer
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 558-564;

O

  1. O'Donnell, M E

    1. Inhibition of Na+ influx and DNA synthesis in human fibroblasts and neuroblastoma-glioma hybrid cells by amiloride analogs.
      M E O'Donnell, E Cragoe and M L Villereal
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 368-372;

  2. Oates, J A

    1. Prostaglandin biosynthesis does not participate in hypercapnia-induced cerebral vasodilatation in the dog.
      E K Jackson, J F Gerkens, J B Zimmerman, H D Uderman, J A Oates, R J Workman and R A Branch
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 486-492;

  3. Okudaira, H

    1. Correlation between cholinesterase inhibition and reduction in muscarinic receptors and choline uptake by repeated diisopropylfluorophosphate administration: antagonism by physostigmine and atropine.
      S Yamada, M Isogai, H Okudaira and E Hayashi
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 519-525;

  4. Osnes, J B

    1. Demonstration of an alpha adrenoceptor-mediated inotropic effect of norepinephrine in rabbit papillary muscle.
      H Aass, T Skomedal and J B Osnes
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 572-578;

P

  1. Patil, P N

    1. Evaluation of the adrenergic effects of a novel optically active catecholamidine in vitro and in vivo: differential application of the Easson-Stedman hypothesis to alpha and beta adrenoceptors.
      R R Ruffolo, J W Banning, P N Patil, A Hamada and D D Miller
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 469-476;

  2. Patrick, K

    1. Pharmacokinetics of methylphenidate in man, rat and monkey.
      W Wargin, K Patrick, C Kilts, C T Gualtieri, K Ellington, R A Mueller, G Kraemer and G R Breese
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 382-386;

  3. Perkins, M N

    1. Pharmacology and regional variations of quinolinic acid-evoked excitations in the rat central nervous system.
      M N Perkins and T W Stone
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 551-557;

  4. Pfaff, D W

    1. Spinal serotonin (5-HT) receptor subtypes and nociception.
      F P Zemlan, L M Kow and D W Pfaff
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 477-485;

  5. Privitera, P J

    1. Adrenergic nerve stimulation-induced release of propranolol from the perfused hindlimb and spleen of the dog and associated changes in postjunctional response.
      M P Russell, J G Webb, T Walle, H B Daniell, P J Privitera and T E Gaffney
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 324-329;

R

  1. Raitano, L A

    1. Behavioral effects of the optical isomers of methadone in the rat during acute and chronic administration.
      L A Raitano and D E McMillan
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 440-448;

  2. Rastogi, S K

    1. Effects of chronic phencyclidine administration on the schedule-controlled behavior of rats.
      M J Brocco, S K Rastogi and D E McMillan
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 449-454;

  3. Richard, J W

    1. Multiple opiate receptor affinities of kappa and agonist/antagonist analgesics: in vivo assessment.
      P L Wood, D Sanschagrin, J W Richard and M Thakur
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 545-550;

  4. Rosella-Dampman, L M

    1. Naltrexone effects on plasma vasopressin concentration elevated and lowered by various stimuli.
      L M Rosella-Dampman, L C Keil, O Chee and J Y Summy-Long
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 373-381;

  5. Ruffolo, R R

    1. Evaluation of the adrenergic effects of a novel optically active catecholamidine in vitro and in vivo: differential application of the Easson-Stedman hypothesis to alpha and beta adrenoceptors.
      R R Ruffolo, J W Banning, P N Patil, A Hamada and D D Miller
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 469-476;

  6. Russell, M P

    1. Adrenergic nerve stimulation-induced release of propranolol from the perfused hindlimb and spleen of the dog and associated changes in postjunctional response.
      M P Russell, J G Webb, T Walle, H B Daniell, P J Privitera and T E Gaffney
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 324-329;

S

  1. Saintsing, D G

    1. Production of prostaglandins E2 and F2 alpha in the freshwater mussel Ligumia subrostrata: relation to sodium transport.
      D G Saintsing, D H Hwang and T H Dietz
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 455-461;

  2. Sanschagrin, D

    1. Multiple opiate receptor affinities of kappa and agonist/antagonist analgesics: in vivo assessment.
      P L Wood, D Sanschagrin, J W Richard and M Thakur
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 545-550;

  3. Schuster, C R

    1. Interaction between the effects of intragastric meals and drugs on feeding in rhesus monkeys.
      R W Foltin and C R Schuster
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 405-410;
    2. Effects of psychomotor stimulants, alone and in pairs, on milk drinking in the rat after intraperitoneal and intragastric administration.
      R W Foltin, W L Woolverton and C R Schuster
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 411-418;

  4. Shiverick, K T

    1. Effects of chronic administration of mestranol on alpha and beta adrenergic responsiveness in female rats.
      K T Shiverick, K Hutchins, D C Kikta, N Squires and M J Fregly
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 362-367;

  5. Skomedal, T

    1. Demonstration of an alpha adrenoceptor-mediated inotropic effect of norepinephrine in rabbit papillary muscle.
      H Aass, T Skomedal and J B Osnes
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 572-578;

  6. Soubrie, P

    1. Chlordiazepoxide reduces in vivo serotonin release in the basal ganglia of encéphale isolé but not anesthetized cats: evidence for a dorsal raphe site of action.
      P Soubrie, C Blas, A Ferron and J Glowinski
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 526-532;

  7. Squires, N

    1. Effects of chronic administration of mestranol on alpha and beta adrenergic responsiveness in female rats.
      K T Shiverick, K Hutchins, D C Kikta, N Squires and M J Fregly
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 362-367;

  8. Steg, B D

    1. Synergistic effect of modest volume expansion on the diuretic and natriuretic action of guanabenz.
      J W Strandhoy, M Morris, B D Steg and V M Buckalew
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 419-424;

  9. Stephens, J K

    1. Differential sensitivity of hypothalamic norepinephrine and striatal dopamine to catecholamine-depleting agents.
      G S Takimoto, J D Stittsworth, B R Bianchi and J K Stephens
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 432-439;

  10. Stittsworth, J D

    1. Differential sensitivity of hypothalamic norepinephrine and striatal dopamine to catecholamine-depleting agents.
      G S Takimoto, J D Stittsworth, B R Bianchi and J K Stephens
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 432-439;

  11. Stone, T W

    1. Pharmacology and regional variations of quinolinic acid-evoked excitations in the rat central nervous system.
      M N Perkins and T W Stone
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 551-557;

  12. Strandhoy, J W

    1. Synergistic effect of modest volume expansion on the diuretic and natriuretic action of guanabenz.
      J W Strandhoy, M Morris, B D Steg and V M Buckalew
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 419-424;

  13. Strong, R

    1. Ethanol-induced disordering of membranes from different age groups of C57BL/6NNIA mice.
      H J Armbrecht, W G Wood, R W Wise, J B Walsh, B N Thomas and R Strong
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 387-391;

  14. Summy-Long, J Y

    1. Naltrexone effects on plasma vasopressin concentration elevated and lowered by various stimuli.
      L M Rosella-Dampman, L C Keil, O Chee and J Y Summy-Long
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 373-381;

T

  1. Takimoto, G S

    1. Differential sensitivity of hypothalamic norepinephrine and striatal dopamine to catecholamine-depleting agents.
      G S Takimoto, J D Stittsworth, B R Bianchi and J K Stephens
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 432-439;

  2. Thakur, M

    1. Multiple opiate receptor affinities of kappa and agonist/antagonist analgesics: in vivo assessment.
      P L Wood, D Sanschagrin, J W Richard and M Thakur
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 545-550;

  3. Thomas, B N

    1. Ethanol-induced disordering of membranes from different age groups of C57BL/6NNIA mice.
      H J Armbrecht, W G Wood, R W Wise, J B Walsh, B N Thomas and R Strong
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 387-391;

  4. Timmermans, P B

    1. Quantitative aspects of alpha adrenergic effects induced by clonidine-like imidazolidines. III. Comparison of central and peripheral alpha-1 and alpha-2 adrenoceptors.
      A de Jonge, P B Timmermans and P A van Zwieten
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 565-571;

U

  1. Uderman, H D

    1. Prostaglandin biosynthesis does not participate in hypercapnia-induced cerebral vasodilatation in the dog.
      E K Jackson, J F Gerkens, J B Zimmerman, H D Uderman, J A Oates, R J Workman and R A Branch
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 486-492;

  2. Ueda, N

    1. Effects of Met-enkephalin on the substance P-ergic and cholinergic responses in the rabbit iris sphincter muscle.
      N Ueda, I Muramatsu, H Hayashi and M Fujiwara
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 507-511;

V

  1. van Zwieten, P A

    1. Quantitative aspects of alpha adrenergic effects induced by clonidine-like imidazolidines. III. Comparison of central and peripheral alpha-1 and alpha-2 adrenoceptors.
      A de Jonge, P B Timmermans and P A van Zwieten
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 565-571;

  2. Verbeuren, T J

    1. Accumulation and release of [3H]-5-hydroxytryptamine in saphenous veins and cerebral arteries of the dog.
      T J Verbeuren, F H Jordaens and A G Herman
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 579-588;

  3. Villereal, M L

    1. Inhibition of Na+ influx and DNA synthesis in human fibroblasts and neuroblastoma-glioma hybrid cells by amiloride analogs.
      M E O'Donnell, E Cragoe and M L Villereal
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 368-372;

W

  1. Walle, T

    1. Adrenergic nerve stimulation-induced release of propranolol from the perfused hindlimb and spleen of the dog and associated changes in postjunctional response.
      M P Russell, J G Webb, T Walle, H B Daniell, P J Privitera and T E Gaffney
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 324-329;

  2. Walsh, J B

    1. Ethanol-induced disordering of membranes from different age groups of C57BL/6NNIA mice.
      H J Armbrecht, W G Wood, R W Wise, J B Walsh, B N Thomas and R Strong
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 387-391;

  3. Wargin, W

    1. Pharmacokinetics of methylphenidate in man, rat and monkey.
      W Wargin, K Patrick, C Kilts, C T Gualtieri, K Ellington, R A Mueller, G Kraemer and G R Breese
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 382-386;

  4. Webb, J G

    1. Adrenergic nerve stimulation-induced release of propranolol from the perfused hindlimb and spleen of the dog and associated changes in postjunctional response.
      M P Russell, J G Webb, T Walle, H B Daniell, P J Privitera and T E Gaffney
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 324-329;

  5. Wetzel, G T

    1. Relationships between choline uptake, acetylcholine synthesis and acetylcholine release in isolated rat atria.
      G T Wetzel and J H Brown
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 343-348;

  6. Wilcox, G L

    1. Pharmacological characterization of substance P-induced nociception in mice: modulation by opioid and noradrenergic agonists at the spinal level.
      J L Hylden and G L Wilcox
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 398-404;

  7. Wise, R W

    1. Ethanol-induced disordering of membranes from different age groups of C57BL/6NNIA mice.
      H J Armbrecht, W G Wood, R W Wise, J B Walsh, B N Thomas and R Strong
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 387-391;

  8. Wong, S

    1. Anti-inflammatory and antiarthritic evaluation of acetaminophen and its potentiation of tolmetin.
      S Wong and J F Gardocki
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 625-632;

  9. Wood, P L

    1. Multiple opiate receptor affinities of kappa and agonist/antagonist analgesics: in vivo assessment.
      P L Wood, D Sanschagrin, J W Richard and M Thakur
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 545-550;

  10. Wood, W G

    1. Ethanol-induced disordering of membranes from different age groups of C57BL/6NNIA mice.
      H J Armbrecht, W G Wood, R W Wise, J B Walsh, B N Thomas and R Strong
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 387-391;

  11. Woolverton, W L

    1. Effects of psychomotor stimulants, alone and in pairs, on milk drinking in the rat after intraperitoneal and intragastric administration.
      R W Foltin, W L Woolverton and C R Schuster
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 411-418;

  12. Worcel, M

    1. Pre- and postjunctional actions of hydralazine in vascular and nonvascular smooth muscle in vitro.
      N L Brown, C Chevillard and M Worcel
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 512-518;

  13. Workman, R J

    1. Prostaglandin biosynthesis does not participate in hypercapnia-induced cerebral vasodilatation in the dog.
      E K Jackson, J F Gerkens, J B Zimmerman, H D Uderman, J A Oates, R J Workman and R A Branch
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 486-492;

Y

  1. Yaksh, T L

    1. In vivo studies on spinal opiate receptor systems mediating antinociception. I. Mu and delta receptor profiles in the primate.
      T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 303-316;

  2. Yamada, K A

    1. Pentobarbital causes cardiorespiratory depression by interacting with a GABAergic system at the ventral surface of the medulla.
      K A Yamada, J M Moerschbaecher, P Hamosh and R A Gillis
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 349-355;

  3. Yamada, S

    1. Correlation between cholinesterase inhibition and reduction in muscarinic receptors and choline uptake by repeated diisopropylfluorophosphate administration: antagonism by physostigmine and atropine.
      S Yamada, M Isogai, H Okudaira and E Hayashi
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 519-525;

Z

  1. Zemlan, F P

    1. Spinal serotonin (5-HT) receptor subtypes and nociception.
      F P Zemlan, L M Kow and D W Pfaff
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 477-485;

  2. Zimmerman, J B

    1. Prostaglandin biosynthesis does not participate in hypercapnia-induced cerebral vasodilatation in the dog.
      E K Jackson, J F Gerkens, J B Zimmerman, H D Uderman, J A Oates, R J Workman and R A Branch
      Journal of Pharmacology and Experimental Therapeutics August 1983, 226 (2) 486-492;
Back to top

In this issue

Advertisement